Vilhelmas Bajoras

Dr. Vilhelmas Bajoras


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2021 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
FSFadi J. Sawaya
Fadi J. Sawaya
VBVilhelmas Bajoras
Vilhelmas Bajoras
MVMaarten Vanhaverbeke
Maarten Vanhaverbeke
CWChristina Wang
Christina Wang
GBGintautas Bieliauskas
Gintautas Bieliauskas
OBOle De Backer
Ole De Backer
Transcatheter aortic valve implantation (TAVI) is currently an established therapy for elderly patients with symptomatic severe aortic valve stenosis across all surgical risk categories. Access is an important aspect when planning for and performing TAVI. The superiority of a transfemoral (TF) approach compared to a transthoracic (transapical, direct aortic) approach has been demonstrated in several studies. Recently, the introduction of intravascular lithotripsy (IVL) has made it possible to treat patients with calcified iliofemoral disease by TF approach. This article aimed to provide a comprehensive overview on the following aspects: (1) preprocedural planning for IVL-assisted TF-TAVI; (2) procedural aspects in IVL-assisted TF-TAVI; (3) outcomes of IVL-assisted TF-TAVI in an experienced TAVI center; and (4) literature review and discussion of this new emerging approach.

21 December 2022 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
XWXi Wang
Xi Wang
IWIvan Wong
Ivan Wong
VBVilhelmas Bajoras
Vilhelmas Bajoras
MVMaarten Vanhaverbeke
Maarten Vanhaverbeke
PNPhilippe Nuyens
Philippe Nuyens
LSLars Sondergaard
Lars Sondergaard
Background: Use of a right−left (R−L) cusp overlap view for transcatheter aortic valve replacement (TAVR) with self‐expanding valves has recently been proposed aiming to reduce permanent pacemaker implantation (PPMI). An objective, data‐driven explanation for this observation is missing.Aims: To assess the impact of different implantation techniques on the risk of PPMI following TAVR with the Portico/NavitorTM transcatheter heart valve (THV; Abbott).Methods: A TAVR‐population treated with Portico/NavitorTM had the THV implanted in a right versus left anterior oblique (RAO/LAO) fluoroscopic view with no parallax in the delivery system. The impact of these different implantation views on the spatial relationship between THV and native aortic annulus and the risk of conduction disturbances and PPMI after TAVR was studied.Results: A total of 366 matched TAVR patients were studied: 183 in the RAO group and 183 in the LAO group. The degree of aortic annulus plane tilt was significantly smaller in the RAO versus LAO group (median: 0° vs. 23°, p < 0.001), with no plane tilt in 105 out of 183 cases (57.3%) in the RAO group. At 30 days after TAVR, the overall PPMI and guideline‐directed PPMI rates were 12.6% versus 18.0% (p = 0.15) and 8.2% versus 15.3% (p = 0.04) in the RAO versus LAO group, respectively.Conclusions: Use of a R−L cusp overlap (RAO‐caudal) view for implantation of the Portico/NavitorTM valve results in less tilt of the native aortic annulus plane and a clear trend toward a lower 30‐day PPMI rate as compared to TAVR using the conventional LAO implantation view.

1 June 2016 in International Journal of Cardiology
Verified
Journal Article
Open access
Julius BogomolovasJulius Bogomolovas
Julius Bogomolovas
AGAlexander Gasch
Alexander Gasch
VBVilhelmas Bajoras
Vilhelmas Bajoras
DKDovilė Karčiauskaitė
Dovilė Karčiauskaitė
PŠPranas Šerpytis
Pranas Šerpytis
SLSiegfried Labeit
Siegfried Labeit

2 April 2022 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
VBVilhelmas Bajoras
Vilhelmas Bajoras
PNPhilippe Nuyens
Philippe Nuyens
MVMaarten Vanhaverbeke
Maarten Vanhaverbeke
XWXi Wang
Xi Wang
GBGintautas Bieliauskas
Gintautas Bieliauskas
LSLars Sondergaard
Lars Sondergaard

18 March 2022 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
TBTomas Baltrūnas
Tomas Baltrūnas
VLVaidas Labunskas
Vaidas Labunskas
VDVilius Dambrauskas
Vilius Dambrauskas
EKEvaldas Kalvaitis
Evaldas Kalvaitis
VBVilhelmas Bajoras
Vilhelmas Bajoras

25 November 2021 in Medicina
Verified
Journal Article
Open access
PDF file
PBPovilas Budrys
Povilas Budrys
MLMindaugas Lizaitis
Mindaugas Lizaitis
KCKamile Cerlinskaite-Bajore
Kamile Cerlinskaite-Bajore
VBVilhelmas Bajoras
Vilhelmas Bajoras
GRGreta Rodevic
Greta Rodevic
GDGiedrius Davidavicius
Giedrius Davidavicius
Background and objectives: early reports showed a decrease in admission rates and an increase in mortality of patients with acute myocardial infarction (AMI) during the first wave of COVID-19 pandemic. We sought to investigate whether the COVID-19 pandemic and associated lockdown had an impact on the ischemia time and prognosis of patients suffering from AMI in the settings of low COVID-19 burden. Materials and Methods: we conducted a retrospective data analysis from a tertiary center in Lithuania of 818 patients with AMI. Data were collected from 1 March to 30 June in 2020 during the peri-lockdown period (2020 group; n = 278) and compared to the same period last year (2019 group; n = 326). The primary study endpoint was all-cause mortality during 3 months of follow-up. Secondary endpoints were heart failure severity (Killip class) on admission and ischemia time in patients with acute ST segment elevation myocardial infarction (STEMI). Results: there was a reduction of 14.7% in admission rate for acute myocardial infarction (AMI) during the peri-lockdown period. The 3-month mortality rate did not differ significantly (6.9% in 2020 vs. 10.5% in 2019, p = 0.341 for STEMI patients; 5.3% in 2020 vs. 2.6% in 2019, p = 0.374 for patients with acute myocardial infarction without ST segment elevation (NSTEMI)). More STEMI patients presented with Killip IV class in 2019 (13.5% vs. 5.5%, p = 0.043, respectively). There was an increase of door-to-PCI time (54.0 [42.0–86.0] in 2019; 63.5 [48.3–97.5] in 2020, p = 0.018) and first medical contact (FMC)-to-PCI time (101.0 [82.5–120.8] in 2019; 115 [97.0–154.5] in 2020, p = 0.01) during the pandemic period. Conclusions: There was a 14.7% reduction of admissions for AMI during the first wave of COVID-19. FMC-to-PCI time increased during the peri-lockdown period, however, it did not translate into worse survival during follow-up.